[ad_1]
Millions of Americans those whose immune system has been compromised by disease or medical treatment, and those who have already been vaccinated with Covid vaccine and Pfizer or Moderna vaccine, will be allowed to receive a third dose, according to decisions the federation made Thursday night and Friday.
The Food and Drug Administration’s decision by the Advisory Committee on Immunization Practices, an external advisory body to the Centers for Disease Control and Prevention, allow U.S. healthcare providers to investigate for contagious and contagious cancers. they are not fully protected double shot — and in patients who had previously received non-prescription medication alone. Ideally, they change the standard vaccine for people with weakened immune system in two to three doses, and the third dose is given 28 days or more.
But it is not a change of blanket. It affects only those people whom the FDA and ACIP call “serious neglect of the immune system.” Allows for a third shot for 12 years or more, as no vaccine is allowed for preterm infants or children. And it does not condone any further shooting of people with an autoimmune disease who are among the 12 million people who have received the Johnson & Johnson vaccine, because there was no foreknowledge of how to do it.
Both the FDA and the committee were careful not to refer to the third category as “extracurricular,” hoping to differentiate between promoting primary immunity in low-income populations, and restoring adequate immunity in the rest of the population if vaccine potential spreads against other future species. But, all over the world, this move can remain controversial. The World Health Organization has called on rich countries to stop providing more drugs until poorer nations get more shots fired.
The idea of increasing the number of people with the immune system has been coming up for some time. ACIP, a group of medical researchers and representatives of professional organizations that support the CDC vaccination program, analyzed the evacuation evidence last month. CDC leader Rochelle Walensky announced his arrival Thursday afternoon at a White House Covid-19 response meeting. “This is happening to ensure that those at risk — who may need a large amount of medication to address their response to the vaccine — are protected from Covid-19,” he said.
A FDA he changed his instructions at the vaccine at the end of Thursday night, and changed the Emergency Requirements for Pfizer and Moderna routes to include a list of three doctors and prepare for the council, which had already scheduled a meeting Friday morning. The meeting ended with a single vote in favor of three quarters.
But what led to this change – along with the large number of dangerous beverages available in the US – was a study from Canada and France which were published Wednesday and Thursday in New England Journal of Medicine (although shared with government agencies in the past). All of them reported that small groups of vaccines who received two vaccines had fewer antibodies, but gained greater immunity after receiving the third dose.
“I believe the results are convincing; I think it’s a slam dunk,” Atul Humar, a doctor and director of transplantation at the University of Toronto and senior Canadian prosecutor, said Thursday before the FDA and CDC. This study, in 120 transplant patients, not only increased antibody mutations, but also higher T-cell responses received by a third party compared with those receiving placebo. “I think the results are convincing enough that this will help change the technology, and also give a third chance to these patients,” he said.
[ad_2]
Source link
